Purchase Order HT941023P2070
- Not listed
- The Defense Health Agency (DOD) awarded a $250,000 firm fixed price purchase order to Karius, Inc., doing business as Karius Inc., located in San Diego, California. The contract is for Quantitative Next-Gen Sequencing Testing Services and has a period of performance from October 1, 2022 through September 30, 2023. Karius provides genomic sequencing and bioinformatics analysis services to identify pathogens and monitor antimicrobial resistance. No applicable subcontractors were identified in...
- This is a firm fixed price purchase order awarded by the Defense Health Agency (DHA) to Karius, Inc. for quantitative next-generation sequencing testing services. The $240,000 contract supports DHA programs through September 2023 and leverages Karius' expertise in genomic sequencing to rapidly screen patients for various pathogens. This is a sole source award, as Karius is the only commercial laboratory capable of providing the requested cell-free DNA testing from plasma samples with 24-72...
- The Department of Veterans Affairs, through Veterans Integrated Service Network 8, awarded a delivery order valued at $46,000 to Karius, Inc. for the provision of next-generation sequencing (NGS) testing services. This delivery order, effective through July 31, 2025, represents the third year of testing delivery under a firm fixed-price contract structure with no set-aside designation. Karius, Inc., headquartered in Redwood City, California, is a specialized life sciences company focused on...
- Karius, Inc. has been awarded a $22,000 delivery order by Veterans Integrated Service Network 17 (VISN 17), a civilian agency within the Department of Veterans Affairs, for its Karius Next Generation Sequencing Test. The contract, issued on April 1, 2026, with an ultimate completion date of March 31, 2027, represents a firm fixed-price delivery order without a set-aside designation. The place of performance is located in Redwood City, California, where Karius, Inc. maintains its headquarters....
- This is a $44,000 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Karius, Inc., a life sciences company specializing in advanced molecular diagnostic testing and next-generation sequencing (NGS) technologies focused on infectious disease detection. The contract is for the procurement of molecular diagnostic testing services, with an ultimate completion date of September 14, 2026. Karius, Inc. has previously held Indefinite Delivery...
- This contract was awarded by the National Institutes of Health (NIH) Clinical Center to Karius, Inc., a life sciences company specializing in diagnostic testing for infectious diseases. The contract, valued at $80,000.00, is for the provision of molecular diagnostic testing services using Karius' liquid biopsy technology to rapidly screen patients for various pathogens. The testing services will be delivered within 3-4 days of specimen receipt. This is a firm fixed-price purchase order...
- The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 has awarded Karius, Inc. a firm-fixed-price delivery order contract for its Karius Next Generation Sequencing (NGS) diagnostic test. The contract has a ceiling value of $60,000 and a performance period from August 1, 2023 to July 31, 2024. This award is part of a larger $600,000 Indefinite Delivery Contract (IDC) that Karius holds with the VA VHA, which has an ultimate completion date of July 31, 2027. The...
- On April 1, 2025, the Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a delivery order valued at $22,000 to Karius, Inc. under contract 36C25725D0031 (Order #36C25725N0219). This firm fixed-price delivery order, with an ultimate completion date of March 31, 2026, represents performance at the contractor's location in Harlingen, Texas. The award was issued without set-aside designation and leverages Karius, Inc.'s specialized capabilities in next-generation...
- This $13,447.16 firm fixed price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract is to provide a NextSeq DNA library preparation kit and related consumables to support nucleic acid sequencing capabilities at the Naval Health Research Center's Biological Defense Research Directorate in San Diego, California. The award is not associated with a larger...
- This is a firm fixed-price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genetic analysis instruments and reagents. The contract, valued at $98,988.18, is for the provision of Illumina's COVIDSeq Test and associated sequencing consumables and reagents. The products will be used in laboratories at the Naval Health Research Center in San Diego, California to support COVID-19 characterization and research. The contract was...
This federal contract award is for a Quantitative Next-Gen Sequencing Test to be provided to the Naval Medical Center San Diego Lab Department. The $240,000.00 firm fixed-price purchase order was awarded to Karius, Inc., a life sciences company specializing in advanced molecular diagnostic testing and next-generation sequencing technologies. The contract, which does not have a set-aside designation, has an ultimate completion date of September 30, 2027 and was awarded on October 1, 2023. Karius will provide supplemental and expedited limited reference laboratory testing services to the Naval Medical Center San Diego in addition to standard lab mail outs on a separate contract. The contract is funded by the Defense Health Agency, which is an alternate name for the Department of Defense's Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $0 | 6/26/25 | |
| P00003 | Funding Only Action | $60.0k | 12/9/24 | |
| P00002 | Exercise an Option | $0 | 9/19/24 | |
| P00001 | Funding Only Action | $60.0k | 1/8/24 | |
| Not listed | Not listed | $0 | 9/21/23 |